News & Events

9/9/2020

Asian Lean Patients With NAFLD Are 53% Less Likely To Have Cirrhosis, Cardiovascular, And Metabolic Diseases - Latest Data Findings Released From TARGET-NASH Study

9/1/2020

EASL 2020: TARGET-NASH Oral Presentation & Abstract Poster Recap

8/28/2020

Target RWE Builds Growing COVID-19 Data Set of 70,000+ Patients, Announces Published Data Findings

8/24/2020

TARGET-NASH Expands to Europe, Enrolls First Participant

8/17/2020

TARGET-DERM Real-World Evidence Study Reaches 1,000 Enrolled Participants

5/7/2020

Novel Real-World Data Findings From Ongoing TARGET-IBD Study Published In DDW Proceedings

4/14/2020

TARGET-NASH Observational Study Reaches 5,000 Enrolled Patients

3/18/2020

COVID-19 Response

3/17/2020

TARGET PharmaSolutions Expands TARGET-DERM Research Community with Two New Industry Partnerships

3/13/2020

TARGET PharmaSolutions Launches Real-World Asthma Study

2/20/2020

TARGET-IBD Poster & Oral Presentation at ECCO

2/13/2020

TARGET PharmaSolutions Appoints Neal Bibeau as Chief Executive Officer

11/21/2019

TARGET-IBD Research Receives Presidential Poster Award And Outstanding Presenter Award At 2019 American College Of Gastroenterology Annual Scientific Meeting

8/15/2019

Executive Voice: She keeps the Triangle on target in life sciences

4/3/2019

2019 Women in Business Award!

2/27/2019

TARGET PharmaSolutions to Advance Dermatology Research, including Atopic Dermatitis, through New Collaboration

2/13/2019

TARGET PharmaSolutions Launches TARGET-DERM Real-World Observational Study to Advance the Understanding of Atopic Dermatitis (Eczema) and Other Immune-Mediated Inflammatory Skin Conditions

12/3/2018

TARGET PharmaSolutions Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research

11/20/2018

TARGET PharmaSolutions to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences

10/31/2018

TARGET PharmaSolutions Initiates a New Community, TARGET-HBV, to Advance the Understanding of Hepatitis B

1/10/2019

TARGET PharmaSolutions to advance NASH Research through new collaboration

10/20/2017

Why big pharma is partnering with this Chapel Hill data company - Triangle Business Journal

10/19/2017

Boehringer Ingelheim partners with TARGET PharmaSolutions to Progress NASH Research

10/19/2017

Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

10/12/2017

Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

8/18/2017

Alumna Meg Powell Talks with Young Innovators about Clinical Trials

8/2/2017

TARGET PharmaSolutions Enrolls First Participant in its Inflammatory Bowel Disease (IBD) Community

4/20/2017

Allergan Partners with TARGET PharmaSolutions to Advance NASH Research

2/2/2017

TARGET PharmaSolutions Novel Clinical Data Model Helps Drug Industry

11/10/2016

TARGET PharmaSolutions Partners with Bristol-Myers Squibb, Offering a New Platform to Collect Real World Data

11/1/2016